ArticleJournal of oncology2022

Anlotinib Inhibits Tumor Angiogenesis and Promotes the Anticancer Effect of Radiotherapy on Esophageal Cancer through Inhibiting EphA2.

Zhenlin Gu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.